No Data
No Data
No Data
No Data
No Data
China Touyun Tech Widens Loss in 2023 Amid Lower Sales Orders
China Touyun Tech Group (HKG:1332) recorded an increase in attributable loss for 2023 to HK$268.9 million, from HK$198.1 million yuan a year ago, according to the company's annual report posted on the
MT NewswiresApr 30 17:05
透雲生物:2023年年報
Futu NewsApr 29 22:35 · Announcements
Touyun Biotech (01332) released annual results, losses attributable to shareholders of 269 million yuan, an increase of 35.78% year-on-year
According to the Zhitong Finance App, Touyun Biotech (01332) announced its annual results for the year ended December 31, 2023. The group achieved gross profit of HK$55.99 million during the period, a year-on-year decrease of 56.13%; shareholders' losses of 269 million yuan, an increase of 35.78% over the previous year; and a basic loss of 9.58 HK cents per share. According to the announcement, for the year ended 31 December 2023, the Group obtained revenue of approximately HK$198.6 million (2022: HK$315.8 million), a decrease of approximately 37.1% compared to last year. The decrease in turnover was mainly due to a decrease in sales orders for packaged products.
Zhitong FinanceMar 29 00:42
TOUYUN BIOTECH: ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023
Futu NewsMar 28 21:59 · Announcements
Touyun Biotech (01332.HK) held a board meeting on March 28 to approve publication of annual results
Gelonghui, March 14, 丨 Touyun Biotech (01332.HK) announced that the company will hold a board meeting on March 28, 2024 (Thursday) to approve (among other things) the publication of the annual results announcements of the company and its subsidiaries for the year ended 31 December 2023, and to consider the payment of a final dividend.
Gelonghui FinanceMar 14 16:50
TOUYUN BIOTECH: INTERIM REPORT 2023
Futu NewsSep 28, 2023 17:29 · Announcements
No Data
No Data